By Sharon Zhang, Truthout
A new analysis by Public Citizen found that the U.S. is spending nearly double what the rest of the world spends combined for key drugs. The report offers further evidence that the country is in dire need of pharmaceutical drug price reformation, which progressives are fighting for through the Build Back Better Act.
The report finds that, for the 20 top-selling drugs worldwide, U.S. sales totaled $101.1 billion, while sales of the same drugs to the rest of the world totaled almost $57 billion in 2020. For 11 of the drugs, revenue in the U.S. was double that of the rest of the world combined. And for 11 of the 13 pharmaceutical companies that sell these drugs, U.S. profits made up most of their revenue.
Recent Posts
More Than A Dozen U.S. Officials Sold Stocks Before Trump’s Tariffs Sent The Market Plunging
May 22, 2025
Take Action Now Records show well-timed trades by executive branch employees and congressional aides. Even if they had no insider information, ethics…
The Navy Wants Billions For More Nuke Submarines
May 22, 2025
Take Action Now Long deemed unnecessary, the re-upped SLCM-N venture could cost taxpayers — and national security — big time.By Stavroula Pabst,…
I Was Fired From Emerson College For Speaking Out About Palestine, But I Refuse To Be Silent
May 21, 2025
Take Action Now Anna Feder is suing Emerson College for firing her over her Palestine activism. She says she will never stop advocating for a free…
The Path To Medicare for All
May 21, 2025
Take Action Now How can the U.S. take steps to join the rest of the developed world in adopting single-payer health care?By Dean Baker,…